| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $64.7M | — | +754.7% |
| R&D Expense | $125.7M | — | +214.7% |
| SG&A Expense | $88.6M | — | +272.2% |
| Operating Income | -$271.5M | — | -258.8% |
| Pre-tax Income | $798.2M | — | +2575.9% |
| Income Tax | -$6.4M | — | — |
| Net Income | $805.4M | — | +2597.1% |
| EPS (Basic) | $2.19 | — | +1664.3% |
| EPS (Diluted) | $2.07 | — | +1578.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $493.5M | -52.1% | +209.1% |
| Short-term Investments | $1.54B | +13.1% | +259.3% |
| Accounts Receivable | $98.2M | +47.6% | +936.8% |
| Inventory | $17.1M | +65.9% | — |
| Current Assets | $2.30B | -11.0% | +261.5% |
| Total Assets | $6.69B | +1.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$151.0M | — | -357.3% |
| Capital Expenditures | $8.4M | — | +262.6% |
| Investing Cash Flow | -$391.9M | — | -70.2% |
| Financing Cash Flow | $6.9M | — | -98.1% |
| Free Cash Flow | -$159.4M | — | -351.1% |
| +687.4% |
| Current Liabilities | $163.9M | -1.8% | +238.8% |
| Total Liabilities | $1.70B | -38.2% | +1904.1% |
| Stockholders' Equity | $4.98B | +31.0% | +550.4% |